Insights into prion biology

References

• Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 1044
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144
   PubMed Web of Science ®Google Scholar
• Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264:566 - 569
   PubMed Web of Science ®Google Scholar
• Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823 - 833
   PubMed Web of Science ®Google Scholar
• Brachmann A, Baxa U, Wickner RB. Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J 2005; 24:3082 - 3092
   PubMed Web of Science ®Google Scholar
• King CY, Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 2004; 428:319 - 323
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323 - 328
   PubMed Web of Science ®Google Scholar
• Patel BK, Liebman SW. “Prion-proof” for [PIN+]: Infection with in vitro-made amyloid aggregates of Rnq1p-(132–405) induces [PIN+]. J Mol Biol 2007; 365:773 - 782
   PubMed Web of Science ®Google Scholar
• Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 2002; 99:7402 - 7407
   PubMed Web of Science ®Google Scholar
• Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, et al. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 2010; 285:14083 - 14087
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 1135
   PubMed Web of Science ®Google Scholar
• Pezza JA, Serio TR. Prion propagation: The role of protein dynamics. Prion 2007; 1:36 - 43
   PubMed Web of Science ®Google Scholar
• Sondheimer N, Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 2000; 5:163 - 172
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471 - 474
   PubMed Web of Science ®Google Scholar
• Glover JR, Kowal AS, Schirmer EC, Patino MM, Liu JJ, Lindquist S. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 1997; 89:811 - 819
   PubMed Web of Science ®Google Scholar
• King CY, Tittmann P, Gross H, Gebert R, Aebi M, Wuthrich K. Prion-inducing domain 2–114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 1997; 94:6618 - 6622
   PubMed Web of Science ®Google Scholar
• Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 1999; 283:1339 - 1343
   PubMed Web of Science ®Google Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 813
   PubMed Web of Science ®Google Scholar
• Dos Reis S, Coulary-Salin B, Forge V, Lascu I, Begueret J, Saupe SJ. The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils. J Biol Chem 2002; 277:5703 - 5706
   PubMed Web of Science ®Google Scholar
• Masel J, Jansen VA, Nowak MA. Quantifying the kinetic parameters of prion replication. Biophys Chem 1999; 77:139 - 152
   PubMed Web of Science ®Google Scholar
• Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 1996; 273:622 - 626
   PubMed Web of Science ®Google Scholar
• Satpute-Krishnan P, Serio TR. Prion protein remodelling confers an immediate phenotypic switch. Nature 2005; 437:262 - 265
   PubMed Web of Science ®Google Scholar
• Satpute-Krishnan P, Langseth SX, Serio TR. Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol 2007; 5:24
   PubMed Web of Science ®Google Scholar
• Derdowski A, Sindi SS, Klaips CL, DiSalvo S, Serio TR. A size threshold limits prion transmission and establishes phenotypic diversity. Science 2010; 330:680 - 683
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859 - 7868
   PubMed Web of Science ®Google Scholar
• Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. Interactions among prions and prion “strains” in yeast. Proc Natl Acad Sci USA 2002; 99:16392 - 16399
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 1996; 144:1375 - 1386
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157 - 1165
   PubMed Web of Science ®Google Scholar
• Schlumpberger M, Prusiner SB, Herskowitz I. Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 2001; 21:7035 - 7046
   PubMed Web of Science ®Google Scholar
• Wickner RB, Edskes HK, Shewmaker F, Kryndushkin D, Nemecek J. Prion variants, species barriers, generation and propagation. J Biol 2009; 8:47
   PubMedGoogle Scholar
• Dickinson AG, Meikle VM. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol Gen Genet 1971; 112:73 - 79
   PubMedGoogle Scholar
• Bessen RA, Marsh RF. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 1992; 73:329 - 334
   PubMed Web of Science ®Google Scholar
• Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991; 72:595 - 603
   PubMed Web of Science ®Google Scholar
• Pattison IH, Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Path 1961; 71:101 - 109
   PubMed Web of Science ®Google Scholar
• Fraser H, Dickinson AG. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Path 1973; 83:29 - 40
   PubMed Web of Science ®Google Scholar
• Carp RI, Callahan SM, Sersen EA, Moretz RC. Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination. Intervirology 1984; 21:61 - 69
   PubMed Web of Science ®Google Scholar
• Dickinson AG, Taylor DM. Resistance of scrapie agent to decontamination. N Engl J Med 1978; 299:1413 - 1414
   PubMed Web of Science ®Google Scholar
• Kimberlin RH, Walker CA. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 1978; 39:487 - 496
   PubMed Web of Science ®Google Scholar
• Kimberlin RH, Walker CA, Millson GC, Taylor DM, Robertson PA, Tomlinson AH, et al. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sci 1983; 59:355 - 369
   PubMed Web of Science ®Google Scholar
• Taylor DM, Fernie K, McConnell I, Steele PJ. Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies. Vet Microbiol 1998; 64:33 - 38
   Google Scholar
• Kimberlin RH, Cole S, Walker CA. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. J Gen Biol 1987; 68:1875 - 1881
   Google Scholar
• Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21:6358 - 6366
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 2004; 306:1793 - 1796
   PubMed Web of Science ®Google Scholar
• Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 1998; 273:32230 - 32235
   PubMed Web of Science ®Google Scholar
• Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural basis of yeast prion strain variants. Nature 2007; 449:233 - 237
   PubMed Web of Science ®Google Scholar
• Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton DR, et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 2002; 34:921 - 932
   PubMed Web of Science ®Google Scholar
• Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274:2079 - 2082
   PubMed Web of Science ®Google Scholar
• Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001; 10:854 - 863
   PubMed Web of Science ®Google Scholar
• Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585 - 589
   PubMed Web of Science ®Google Scholar
• Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995; 375:698 - 700
   PubMed Web of Science ®Google Scholar
• Mulcahy ER, Bessen RA. Strain-specific kinetics of prion protein formation in vitro and in vivo. J Biol Chem 2004; 279:1643 - 1649
   PubMed Web of Science ®Google Scholar
• Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 2006; 103:19105 - 19110
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 348
   PubMed Web of Science ®Google Scholar
• Sindi SS, Serio TR. Prion dynamics and the quest for the genetic determinant in protein-only inheritance. Curr Opin Microbiol 2009; 12:623 - 630
   PubMed Web of Science ®Google Scholar
• Serio TR, Lindquist SL. [PSI+]: an epigenetic modulator of translation termination efficiency. Annu Rev Cell Dev Biol 1999; 15:661 - 703
   PubMed Web of Science ®Google Scholar
• Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, et al. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 1995; 14:4365 - 4373
   PubMed Web of Science ®Google Scholar
• Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, Kisselev L, et al. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 1995; 14:4065 - 4072
   PubMed Web of Science ®Google Scholar
• Cox B. [PSI], a cytoplasmic suppressor of super-suppression in yeast. Heredity 1965; 20:505 - 521
   Web of Science ®Google Scholar
• Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 1996; 15:3127 - 3134
   PubMed Web of Science ®Google Scholar
• Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636 - 49643
   PubMed Web of Science ®Google Scholar
• Bagriantsev SN, Kushnirov VV, Liebman SW. Analysis of amyloid aggregates using agarose gel electrophoresis. Meth Enz 2006; 412:33 - 48
   PubMed Web of Science ®Google Scholar
• Byrne LJ, Cole DJ, Cox BS, Ridout MS, Morgan BJ, Tuite MF. The number and transmission of [PSI] prion seeds (Propagons) in the yeast Saccharomyces cerevisiae. PLoS One 2009; 4:4670
   PubMed Web of Science ®Google Scholar
• Allen KD, Wegrzyn RD, Chernova TA, Muller S, Newnam GP, Winslett PA, et al. Hsp70 chaperones as modulators of prion life cycle: novel effects of Ssa and Ssb on the Saccharomyces cerevisiae prion [PSI+]. Genetics 2005; 169:1227 - 1242
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Bradley ME, Zhou P, Liebman SW. The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast. Curr Genet 1999; 35:59 - 67
   PubMed Web of Science ®Google Scholar
• Crapeau M, Marchal C, Cullin C, Maillet L. The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion. Mol Biol Cell 2009; 20:2286 - 2296
   PubMed Web of Science ®Google Scholar
• Edskes HK, Gray VT, Wickner RB. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci USA 1999; 96:1498 - 1503
   PubMed Web of Science ®Google Scholar
• Baudin-Baillieu A, Fernandez-Bellot E, Reine F, Coissac E, Cullin C. Conservation of the prion properties of Ure2p through evolution. Mol Biol Cell 2003; 14:3449 - 3458
   PubMed Web of Science ®Google Scholar
• Kawai-Noma S, Pack CG, Tsuji T, Kinjo M, Taguchi H. Single mother-daughter pair analysis to clarify the diffusion properties of yeast prion Sup35 in guanidine-HCl-treated [PSI] cells. Genes Cells 2009; 4:1045 - 1054
   Web of Science ®Google Scholar
• Haslberger T, Bukau B, Mogk A. Towards a unifying mechanism for ClpB/Hsp104-mediated protein disaggregation and prion propagation. Biochem Cell Biol 2010; 88:63 - 75
   PubMed Web of Science ®Google Scholar
• Ness F, Ferreira P, Cox BS, Tuite MF. Guanidine hydrochloride inhibits the generation of prion “seeds” but not prion protein aggregation in yeast. Mol Cell Biol 2002; 22:5593 - 5605
   PubMed Web of Science ®Google Scholar
• Cox B, Ness F, Tuite M. Analysis of the generation and segregation of propagons: entities that propagate the [PSI+] prion in yeast. Genetics 2003; 165:23 - 33
   PubMed Web of Science ®Google Scholar
• Zhou P, Derkatch IL, Uptain SM, Patino MM, Lindquist S, Liebman SW. The yeast non-Mendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3. EMBO J 1999; 18:1182 - 1191
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257 - 261
   PubMed Web of Science ®Google Scholar
• Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Path 2010; 6:1000859
   PubMed Web of Science ®Google Scholar
• Calvez V, Lenuzza N, Oelz D, Deslys JP, Laurent P, Mouthon F, et al. Size distribution dependence of prion aggregates infectivity. Math Biosci 2009; 217:88 - 99
   PubMed Web of Science ®Google Scholar
• Zampieri M, Legname G, Altafini C. Investigating the conformational stability of prion strains through a kinetic replication model. PLoS Comput Biol 2009; 5:1000420
   PubMed Web of Science ®Google Scholar
• Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci USA 2005; 102:2168 - 2173
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540 - 542
   PubMed Web of Science ®Google Scholar
• Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 1989; 59:847 - 857
   PubMed Web of Science ®Google Scholar
• Wickner RB. Prion diseases: Infectivity versus toxicity. Nature 2011; 470:470 - 471
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, Phuan PW, Perkins B, Ullman J, May BC, Cohen FE, et al. Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci USA 2007; 104:17971 - 17976
   PubMed Web of Science ®Google Scholar
• Vishveshwara N, Bradley ME, Liebman SW. Sequestration of essential proteins causes prion associated toxicity in yeast. Mol Microbiol 2009; 73:1101 - 1114
   PubMed Web of Science ®Google Scholar
• Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992; 66:2096 - 2101
   PubMed Web of Science ®Google Scholar
• Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, Bartz JC. The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Path 2011; 7:1001317
   PubMed Web of Science ®Google Scholar
• Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC. Coinfecting prion strains compete for a limiting cellular resource. J Virol 2010; 84:5706 - 5714
   PubMed Web of Science ®Google Scholar
• Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 1347
   PubMed Web of Science ®Google Scholar
• Dickinson AG, Fraser H, Outram GW. Scrapie incubation time can exceed natural lifespan. Nature 1975; 256:732 - 733
   PubMed Web of Science ®Google Scholar
• Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75:10106 - 10112
   PubMed Web of Science ®Google Scholar
• Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, et al. Search for a prion-specific nucleic acid. J Virol 2005; 79:10796 - 10806
   PubMed Web of Science ®Google Scholar
• Outram GW. Kimberlin RH. The pathogenesis of scrapie in mice. Slow Virus Diseases of Animals and Man 1976; Amsterdam North-Holland 325 - 357
   Google Scholar
• Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, et al. Prion clearance in bigenic mice. J Gen Virol 2005; 86:2913 - 2923
   PubMed Web of Science ®Google Scholar
• Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302:871 - 874
   PubMed Web of Science ®Google Scholar
• Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007; 53:325 - 335
   PubMed Web of Science ®Google Scholar
• Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, et al. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 2006; 116:3204 - 3210
   PubMed Web of Science ®Google Scholar
• White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci USA 2008; 105:10238 - 10243
   PubMed Web of Science ®Google Scholar
• Goldmann W, Chong A, Foster J, Hope J, Hunter N. The shortest known prion protein gene allele occurs in goats, has only three octapeptide repeats and is non-pathogenic. J Gen Virol 1998; 79:3173 - 3176
   PubMed Web of Science ®Google Scholar
• Dickinson AG, Stamp JT, Renwick CC, Rennie JC. Some factors controlling the incidence of scrapie in Cheviot sheep injected with a Cheviot-passaged scrapie agent. J Comp Path 1968; 78:313 - 321
   PubMed Web of Science ®Google Scholar
• Hunter N, Moore L, Hosie BD, Dingwall WS, Greig A. Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland. Vet Rec 1997; 140:59 - 63
   PubMed Web of Science ®Google Scholar
• Laplanche JL, Delasnerie-Laupretre N, Brandel JP, Chatelain J, Beaudry P, Alperovitch A, et al. Molecular genetics of prion diseases in France. French research group on epidemiology of human spongiform encephalopathies. Neurology 1994; 44:2347 - 2351
   PubMedGoogle Scholar
• Belt PB, Muileman IH, Schreuder BE, Bos-de Ruijter J, Gielkens AL, Smits MA. Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol 1995; 76:509 - 517
   PubMed Web of Science ®Google Scholar
• Maciulis A, Hunter N, Wang S, Goldmann W, Hope J, Foote WC. Polymorphisms of a scrapie-associated fibril protein (PrP) gene and their association with susceptibility to experimentally induced scrapie in Cheviot sheep in the United States. Am J Vet Res 1992; 53:1957 - 1960
   PubMed Web of Science ®Google Scholar
• Dickenson AG, Outram GW. Genetic aspects of unconventional virus infections: the basis fo the virino hypothesis. Ciba Foundation Symposium 1988; 135:63 - 83
   PubMedGoogle Scholar
• Bossers A, de Vries R, Smits MA. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 2000; 74:1407 - 1414
   PubMed Web of Science ®Google Scholar
• Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T. Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:826 - 828
   PubMed Web of Science ®Google Scholar
• Hizume M, Kobayashi A, Teruya K, Ohashi H, Ironside JW, Mohri S, et al. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. J Biol Chem 2009; 284:3603 - 3609
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39:767 - 778
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224 - 233
   PubMed Web of Science ®Google Scholar
• Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 1996; 383:685 - 690
   PubMed Web of Science ®Google Scholar
• Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 2003; 126:1333 - 1346
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 936
   PubMed Web of Science ®Google Scholar
• Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069 - 10074
   PubMed Web of Science ®Google Scholar
• Zulianello L, Kaneko K, Scott M, Erpel S, Han D, Cohen FE, et al. Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol 2000; 74:4351 - 4360
   PubMed Web of Science ®Google Scholar
• Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, DeArmond SJ, et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci USA 2002; 99:13079 - 13084
   PubMed Web of Science ®Google Scholar
• Crozet C, Lin Y, Mettling C, Mourton-Gilles C, Corbeau P, Lehmann S, et al. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutants. J Cell Sci 2004; 117:5591 - 5597
   PubMed Web of Science ®Google Scholar
• Furuya K, Kawahara N, Yamakawa Y, Kishida H, Hachiya NS, Nishijima M, et al. Intracerebroventricular delivery of dominant negative prion protein in a mouse model of iatrogenic Creutzfeldt-Jakob disease after dura graft transplantation. Neurosci Lett 2006; 402:222 - 226
   PubMed Web of Science ®Google Scholar
• Toupet K, Compan V, Crozet C, Mourton-Gilles C, Mestre-Frances N, Ibos F, et al. Effective gene therapy in a mouse model of prion diseases. PLoS One 2008; 3:2773
   PubMed Web of Science ®Google Scholar
• Atarashi R, Sim VL, Nishida N, Caughey B, Katamine S. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture. J Virol 2006; 80:7854 - 7862
   PubMed Web of Science ®Google Scholar
• Ott D, Taraborrelli C, Aguzzi A. Novel dominant-negative prion protein mutants identified from a randomized library. Protein Eng Des Sel 2008; 21:623 - 629
   PubMed Web of Science ®Google Scholar
• Prusiner S, Scott M, Foster D, Pan K, Groth D, Mirenda C, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63:673 - 686
   PubMed Web of Science ®Google Scholar
• Scott MR, Kohler R, Foster D, Prusiner SB. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1992; 1:986 - 997
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 1993; 90:10608 - 10612
   PubMed Web of Science ®Google Scholar
• Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83:79 - 90
   PubMed Web of Science ®Google Scholar
• Telling GC, Scott M, Hsiao KK, Foster D, Yang SL, Torchia M, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 1994; 91:9936 - 9940
   PubMed Web of Science ®Google Scholar
• Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci USA 2003; 100:4784 - 4789
   PubMed Web of Science ®Google Scholar
• Geoghegan JC, Miller MB, Kwak AH, Harris BT, Supattapone S. Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Path 2009; 5:1000535
   PubMed Web of Science ®Google Scholar
• Lee CI, Yang Q, Perrier V, Baskakov IV. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. Protein Sci 2007; 16:2166 - 2173
   PubMed Web of Science ®Google Scholar
• Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion and species barriers. Proc Natl Acad Sci USA 2000; 97:5836 - 5841
   PubMed Web of Science ®Google Scholar
• Priola SA. Prion protein and species barriers in the transmissible spongiform encephalopathies. Biomed Pharmacother 1999; 53:27 - 33
   PubMed Web of Science ®Google Scholar
• Priola SA, Caughey B, Race RE, Chesebro B. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 1994; 68:4873 - 4878
   PubMed Web of Science ®Google Scholar
• Masel J, Jansen VA. Designing drugs to stop the formation of prion aggregates and other amyloids. Biophys Chem 2000; 88:47 - 59
   PubMed Web of Science ®Google Scholar
• DePace AH, Santoso A, Hillner P, Weissman JS. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 1998; 93:1241 - 1252
   PubMed Web of Science ®Google Scholar
• Doel SM, McCready SJ, Nierras CR, Cox BS. The dominant PNM2-mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 1994; 137:659 - 670
   PubMed Web of Science ®Google Scholar
• Young C, Cox B. Extrachromosomal elements in a super-suppression system of yeast I. A nuclear gene controlling the inheritance of the extrachromosomal elements. Heredity 1971; 26:413 - 422
   Web of Science ®Google Scholar
• DiSalvo S, Derdowski A, Pezza JA, Serio TR. Dominant-negative prion mutants induce curing through distinct pathways that promote chaperone-mediated aggregate disassembly. Nature Struct Mol Biol 2011; 18:486 - 492
   PubMed Web of Science ®Google Scholar
• Bossers A, Belt P, Raymond GJ, Caughey B, de Vries R, Smits MA. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci USA 1997; 94:4931 - 4936
   PubMed Web of Science ®Google Scholar
• Kochneva-Pervukhova NV, Paushkin SV, Kushnirov VV, Cox BS, Tuite MF, Ter-Avanesyan MD. Mechanism of inhibition of [PSI+] prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein. EMBO J 1998; 17:5805 - 5810
   PubMed Web of Science ®Google Scholar
• Osherovich LZ, Cox BS, Tuite MF, Weissman JS. Dissection and design of yeast prions. PLoS Biol 2004; 2:86
   PubMed Web of Science ®Google Scholar
• Luheshi LM, Dobson CM. Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett 2009; 583:2581 - 2586
   PubMed Web of Science ®Google Scholar
• Bellotti V, Chiti F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol 2008; 18:771 - 779
   PubMed Web of Science ®Google Scholar
• Verges KJ, Smith MH, Toyama BH, Weissman JS. Strain conformation, primary structure and the propagation of the yeast prion [PSI+]. Nat Struct Mol Biol 2011; 18:493 - 499
   PubMed Web of Science ®Google Scholar